Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Tafluprost/Timolol

Australian Public Assessment Report

AusPAR

AusPAR: Tafluprost/Timolol [PDF, 530.53 KB]

AusPAR: Tafluprost/Timolol [Word, 875.11 KB]

Attachment: Product information: Tafluprost/Timolol [PDF, 170.86 KB]

Attachment: Product information: Tafluprost/Timolol [Word, 81.07 KB]

Attachment: Extract from the Clinical Evaluation Report: Tafluprost/Timolol [PDF, 2.82 MB]

Attachment: Extract from the Clinical Evaluation Report: Tafluprost/Timolol [Word, 6.46 MB]

Device/Product Name

Taptiqom 15/5

Active ingredients

Tafluprost/Timolol

AusPAR Date

28 July 2015

Published

18 August 2015

Submission Number

PM-2013-03652-1-5

Submission Type

New fixed dose combination

Decision

Approved